We are live on ! Find out more
CAH icon

Cardinal Health

721 hedge funds and large institutions have $12B invested in Cardinal Health in 2020 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 251 increasing their positions, 267 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more funds holding in top 10

Funds holding in top 10: 513 (+8)

21% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 82

1% more funds holding

Funds holding: 714721 (+7)

6% less repeat investments, than reductions

Existing positions increased: 251 | Existing positions reduced: 267

2.29% less ownership

Funds ownership: 88.25%85.96% (-2.3%)

8% less capital invested

Capital invested by funds: $13.1B → $12B (-$1.04B)

46% less call options, than puts

Call options by funds: $68.2M | Put options by funds: $126M

Holders
721
Holders Change
+7
Holders Change %
+0.98%
% of All Funds
15.86%
Holding in Top 10
13
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+160%
% of All Funds
0.29%
New
99
Increased
251
Reduced
267
Closed
82
Calls
$68.2M
Puts
$126M
Net Calls
-$58.3M
Net Calls Change
-$27M

CAH Hedge Fund Activity: Q1 2020 in Review

721 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q1 2020, worth a combined $12B — down 7.9% from $13.1B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new CAH positions and 82 closed out — a net gain of 17 holders — while 251 added to existing stakes and 267 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $136M. The largest seller was Invesco, cutting an estimated $202M.

  • 721 institutional investors held Cardinal Health (CAH) as of Q1 2020, up from 714 in Q4 2019.
  • Funds reported $12B of Cardinal Health stock for Q1 2020, down 7.9% quarter-over-quarter.
  • 99 funds opened new Cardinal Health positions in Q1 2020 and 82 closed out, a net change of +17 holders.
  • The largest Cardinal Health buyer in Q1 2020 was T. Rowe Price Associates, an estimated $136M added.
  • The largest Cardinal Health seller in Q1 2020 was Invesco, an estimated $202M sold.

Based on aggregated 13F filings for Q1 2020.